Xencor | XNCR - Ebit

Stock Price
11.39
Daily Change
-0.60 -5.00%
Monthly
-20.18%
Yearly
-34.99%
Q1 Forecast
11.72

Xencor reported $-47.52M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 1.45B 4.26B Sep/2025
Alnylam Pharmaceuticals USD -29.96M 34.85M Sep/2025
Amgen USD 3.96B 464M Dec/2025
Arrowhead Research USD 57.82M 223.36M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
MacroGenics USD 20.16M 55.51M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.65B 71M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Xencor USD -47.52M 24.69M Sep/2025